Sansure Biotech Inc. (SHSE:688289) agreed to acquire Zhongshan Sinobioway Hygene Biomedicine Co., Ltd. from a group of seller on January 13, 2025. For the period ended November 30, 2024 Zhongshan Sinobioway Hygene Biomedicine Co., Ltd. reported total assets of CNY 440 million and net assets of CNY 350 million.